Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack. | Zendy

A Burén | Zendy; J Ygge | Zendy

Open Access

Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack.

Author(s) -

A Burén,

J Ygge

Publication year - 1981

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/01.str.12.5.578

Subject(s) - medicine , dipyridamole , platelet aggregation , cerebral infarction , stroke (engine) , incidence (geometry) , ischemic stroke , cardiology , platelet , anesthesia , ischemia , mechanical engineering , physics , optics , engineering

Transient cerebral ischemic attacks (TIA) are an important warning symptom of threatening stroke from cerebral infarction (CI). A local treatment program aimed at identifying as many individuals with TIA as possible and treating them in a uniform manner is desirable. Platelet aggregation inhibitors with a combination of acetylsalicylic acid and dipyridamole (ASA + DP) has been compared with anticoagulants (AC). The average length of treatment was 24 months and all patients received the treatment for at least 6 months. Sixty patients received AC and 65 ASA + DP. Four patients in the ASA + DP group (6 percent) and 2 in the AC group (3.3 percent) sustained cerebral infarction. These figures are essentially lower than the expected incidence of 15--20 percent.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research